Community acquisition of ESBL-producing Escherichia coil: A growing concern

Medical Journal of Australia

Volumn 190, Issue 1, 2009, Pages 45-46

  Denholm, Justin T ^a   Huysmans, Michael ^a   Spelman, Denis ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; AUSTRALIA; BACTERIAL INFECTION; BACTERIUM ISOLATE; COMMUNITY CARE; ENZYME SYNTHESIS; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; LETTER; MORTALITY; NONHUMAN; PREVALENCE; TREATMENT PLANNING;

EID: 58249111617     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02266.x     Document Type: Letter

References (5)

1. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008; 8: 159-166.
2. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 2007; 55: 254-259.
3. Kang C-I, Cheong HS, Chung DR, et al. Clinical features and outcome of community-onset blood-stream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 2008; 27: 85-88.
4. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-686.
5. Pearson J, Turnidge J, Franklin C, Bell J; Australian Group on Antimicrobial Resistance. Prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell 2007; 31: 106-112.